Researchers work on scientific foundation for new forms of therapy in neurodegenerative processes
Protective proteins that mitigate the destruction of nerve cells after a stroke can be administered into the brain through the nose, as Heidelberg University researchers demonstrated using a mouse model.
The team led by Prof. Dr Hilmar Bading at the Interdisciplinary Center for Neurosciences (IZN) is laying the scientific groundwork for new forms of therapy that inhibit degenerative processes in humans. Prof. Bading's team is concentrating on the body's own neuroprotective mechanisms. The most recent results of their work were published in “Molecular Therapy”.
In earlier studies, the Heidelberg researchers showed that brain activity counteracts nerve cell death. “We know that activated nerve cells produce proteins that guard against cell death,” Prof. Bading explains. At the molecular level, the NMDA receptor plays a key role. If these receptors are not located in the nerve cell junctions, or synapses, they can cause massive cell damage and death.
However, the toxic extrasynaptic NMDA receptors and the consequences of their activation can be suppressed. The neurobiologist's research group discovered that the proteins that trigger this suppression, Activin A and SerpinB2, are produced in the nervous system in response to brain activity.
The researchers were particularly interested in how these protective proteins could be administered from the “outside” when their production via activated nerve cells is low, such as after a stroke.
In cooperation with Dr Bettina Buchthal and Ursula Weiß, Prof. Bading was able to demonstrate that nasal administration paves the way for new treatment approaches for neurodegenerative diseases. They verified this concept using a mouse model. According to Hilmar Bading, mice who received this treatment exhibited less brain damage after a stroke in certain regions of the brain.
Thus, the researchers laid the scientific foundation for a simple “nasal spray” that could reduce the disease-related loss of nerve cells. “Unfortunately, it will take many more years before clinical applications in humans are possible. There are a number of testing phases that must be passed before a new compound is approved as a therapeutic drug,” Prof. Bading adds.
The researcher believes that this “non-invasive and extraordinarily simple treatment principle” would be effective not only in cases of acute post-stroke brain damage. It may also help in chronic neurodegenerative diseases associated with increased activation of extrasynaptic NMDA receptors, which includes amyotrophic lateral sclerosis (ALS), Alzheimer's and Huntington's disease.
Communications and Marketing
Press Office, phone +49 6221 54-2311
Prof. Dr. Hilmar Bading
Interdisciplinary Center for Neurosciences
Phone +49 06221 54-8218
B. Buchthal, U. Weiss and H. Bading: Post-injury Nose-to-Brain Delivery of Activin A and SerpinB2 Reduces Brain Damage in a Mouse Stroke Model. Molecular Therapy (published online 23 July 2018), https://doi.org/10.1016/j.ymthe.2018.07.018
Marietta Fuhrmann-Koch | idw - Informationsdienst Wissenschaft
A one-way street for salt
21.09.2018 | Julius-Maximilians-Universität Würzburg
Nerve cells in the human brain can “count”
21.09.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn
The building blocks of matter in our universe were formed in the first 10 microseconds of its existence, according to the currently accepted scientific picture. After the Big Bang about 13.7 billion years ago, matter consisted mainly of quarks and gluons, two types of elementary particles whose interactions are governed by quantum chromodynamics (QCD), the theory of strong interaction. In the early universe, these particles moved (nearly) freely in a quark-gluon plasma.
This is a joint press release of University Muenster and Heidelberg as well as the GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt.
Then, in a phase transition, they combined and formed hadrons, among them the building blocks of atomic nuclei, protons and neutrons. In the current issue of...
Thin-film solar cells made of crystalline silicon are inexpensive and achieve efficiencies of a good 14 percent. However, they could do even better if their shiny surfaces reflected less light. A team led by Prof. Christiane Becker from the Helmholtz-Zentrum Berlin (HZB) has now patented a sophisticated new solution to this problem.
"It is not enough simply to bring more light into the cell," says Christiane Becker. Such surface structures can even ultimately reduce the efficiency by...
A study in the journal Bulletin of Marine Science describes a new, blood-red species of octocoral found in Panama. The species in the genus Thesea was discovered in the threatened low-light reef environment on Hannibal Bank, 60 kilometers off mainland Pacific Panama, by researchers at the Smithsonian Tropical Research Institute in Panama (STRI) and the Centro de Investigación en Ciencias del Mar y Limnología (CIMAR) at the University of Costa Rica.
Scientists established the new species, Thesea dalioi, by comparing its physical traits, such as branch thickness and the bright red colony color, with the...
Scientists have succeeded in observing the first long-distance transfer of information in a magnetic group of materials known as antiferromagnets.
An international team of researchers has mapped Nemo's genome, providing the research community with an invaluable resource to decode the response of fish to...
03.09.2018 | Event News
27.08.2018 | Event News
17.08.2018 | Event News
21.09.2018 | Trade Fair News
21.09.2018 | Earth Sciences
21.09.2018 | Health and Medicine